Pregled bibliografske jedinice broj: 1238964
Adverse events and stroke prevention by interventional left atrial appendage occlusion in patients with low CHA(2)DS(2)-VASc score-results from the multicenter German LAARGE registry
Adverse events and stroke prevention by interventional left atrial appendage occlusion in patients with low CHA(2)DS(2)-VASc score-results from the multicenter German LAARGE registry // Catheterization and cardiovascular interventions, 99 (2022), 7; 2064-2070 doi:10.1002/ccd.30165 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1238964 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Adverse events and stroke prevention by
interventional left atrial appendage occlusion in
patients with low CHA(2)DS(2)-VASc score-results
from the multicenter German LAARGE registry
Autori
Fastner, Christian ; Brachmann, Johannes ; Lewalter, Thorsten ; Zeymer, Uwe ; Sievert, Horst ; Ledwoch, Jakob ; Geist, Volker ; Hochadel, Matthias ; Schneider, Steffen ; Senges, Jochen ; Akin, Ibrahim ; Ansari, Uzair
Izvornik
Catheterization and cardiovascular interventions (1522-1946) 99
(2022), 7;
2064-2070
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
atrial fibrillation ; bleeding risk ; cardiac intervention ; ischemic stroke ; LAA closure ; procedural complications
Sažetak
Background: Interventional left atrial appendage occlusion (LAAO) is routinely performed in patients with nonvalvular atrial fibrillation and contraindications to standard anticoagulation. Aims: We investigated its role in patients at low stroke risk, and compared the effectiveness and safety in patients with low versus high risk. Methods: LAARGE is a prospective registry depicting the clinical reality of LAAO. LAAO was conducted with different standard commercial devices, and follow-up period was 1 year. Patients with started procedure and documented CHA(2)DS(2)- VASc score were selected from the whole database. Results: A total of 638 patients from 38 centers were divided into CHA(2)DS(2)-VASc score <= 2, i.e., low-risk group (10.2%), and >2, i.e., high- risk group (89.8%). The latter had a pronounced cardiovascular risk profile and preceding strokes (0% vs. 23.9% ; p < 0.001). Implantation success was consistently high (97.6%), frequencies of intrahospital major adverse cardiac and cerebrovascular events (0% vs. 0.5%) and other major complications (4.6% vs. 4.0%) were low (each p = not significant [NS]). Numerous moderate complications were also observed in the low-risk patients (12.3% vs. 9.4% ; p = NS). Frequencies of nonfatal strokes (0% vs. 0.7%) and severe bleedings (0% vs. 0.7%) were low (each p = NS). In a specig analysis, patients at very high risk of stroke (i.e., CHA(2)DS(2)-VASc score >4) did not have increased rates of complications or nonfatal strokes in the first year after the procedure. Conclusions: Low-risk patients had no nonfatal strokes and major bleedings within 1 year after hospital discha but had unexpectedly high rates of moderate procedural complications. The indication in these patients should be strictly defined based on an individual benefit-risk assessment.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Split
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE